EUVIMEDOpdag EUVIMED
Crossref

Germ‐cell‐specific transcriptome analysis illuminates the chromatin and ubiquitin pathway in autism spectrum disorders

Sawako Furukawa iD, Jun Nomura iD, Hiroaki Hanafusa, Hiroko Maegawa, Toru Takumi iD

Autism Research · 2023

DOI: 10.1002/aur.2939 ↗

At a glance

Journal article in Autism Research, 2023. Written by Sawako Furukawa and 4 co-authors. Institution: RIKEN Brain Science Institute, Wako, Saitama, Japan. Major MEDLINE topics: Autism Spectrum Disorder. Cited 3 times so far (Crossref); 39 references. Funded by: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Takeda Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Accumulating epidemiological studies have suggested a positive association between advanced paternal age at conception and the increased risk of neurodevelopmental outcomes such as autism spectrum disorder (ASD) in their children. Recent biological studies using human sperm have identified increased de novo mutations in aged fathers, and hyper‐ or hypomethylation has been identified in the sperm from aged rodents. Dysregulation of DNA methylation in sperm may explain the transgenerational effects on the pathogenesis of ASD. However, compared to these epigenetic changes in the sperm of aged males, the effects of inherited predisposition from germ cells are largely unknown. Here, we use single‐cell transcriptome data sets from 13 cell lines, including 12 ASD‐associated CNVs models and control, that are performed neural differentiation from mouse embryonic stem cells. This study performed comprehensive bioinformatic analyses such as gene ontology (GO), network, pathway, and upstream regulator analyses. Through these analyses, we identify several susceptible pathways, such as chromatin and ubiquitin, in addition to translational and oxidative phosphorylation. Our results suggest that dysregulation of epigenetic chromosome remodeling and ubiquitin‐proteasome pathway in the germ cell is a possible modulator for subsequent differentiated cells, sperm, and egg, as a risk factor for the neurodevelopmental disorder.

Subjects

MeSH terms (MEDLINE)

Autism Spectrum DisorderChildHumansMaleAnimalsMiceAgedChromatinUbiquitinSemenGerm CellsGene Expression ProfilingGenetic Predisposition to Disease

Author keywords

autism spectrum disorderbioinformaticscopy number variantsembryonic stem cellsgerm cellssingle-cell analysis

Substances

ChromatinUbiquitin

Authors and institutions

  • RIKEN Brain Science Institute, Wako, Saitama, Japan.
  • Department of Physiology and Cell Biology, Kobe University School of Medicine, Chuo, Kobe, Japan.
  • RIKEN Center for Biosystems Dynamics Research, Chuo, Kobe, Japan.

ORCID profiles: Sawako Furukawa, Jun Nomura, Toru Takumi

Funding

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation
  • Tokyo Biochemical Research Foundation
  • Taiju Life Social Welfare Foundation
  • Naito Foundation
  • Takeda Pharmaceuticals U.S.A.

Cite

APA

Furukawa, S., Nomura, J., Hanafusa, H., Maegawa, H., & Takumi, T. (2023). Germ‐cell‐specific transcriptome analysis illuminates the chromatin and ubiquitin pathway in autism spectrum disorders. Autism Research. https://doi.org/10.1002/aur.2939

Vancouver

Furukawa S, Nomura J, Hanafusa H, Maegawa H, Takumi T. Germ‐cell‐specific transcriptome analysis illuminates the chromatin and ubiquitin pathway in autism spectrum disorders. Autism Research. 2023. doi:10.1002/aur.2939

BibTeX
@article{Furukawa2023,
  author = {Furukawa, Sawako and Nomura, Jun and Hanafusa, Hiroaki and Maegawa, Hiroko and Takumi, Toru},
  title = {Germ‐cell‐specific transcriptome analysis illuminates the chromatin and ubiquitin pathway in autism spectrum disorders},
  journal = {Autism Research},
  year = {2023},
  doi = {10.1002/aur.2939}
}
Start for free →